LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 15 of 15: Calculated dose-response metrics. - Dataset (ID:20252)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | GR_AOC |
|---|---|---|
| MCF7 | AZD 5438 | 0.9502 |
| MCF7 | AZD-6482 | 0.1740 |
| MCF7 | AZD7762 | 0.9688 |
| MCF7 | AZD8055 | 1.0230 |
| MCF7 | AZD8330 | 0.6264 |
| MCF7 | Barasertib | 0.8699 |
| MCF7 | Dactolisib | 0.9129 |
| MCF7 | BI-2536 | 0.9732 |
| MCF7 | SNS-032 | 1.2983 |
| MCF7 | BMS345541 | 0.4417 |
| MCF7 | Brivanib | 0.0943 |
| MCF7 | Buparlisib | 0.8654 |
| MCF7 | BX-912 | 0.4319 |
| MCF7 | Alpelisib | 0.5462 |
| MCF7 | Canertinib | 0.3586 |
| MCF7 | Celastrol | 0.5930 |
| MCF7 | CGP60474 | 1.2480 |
| MCF7 | CHIR-99021 | 0.3458 |
| MCF7 | CP466722 | 0.0241 |
| MCF7 | CP724714 | 0.2236 |
| MCF7 | Crizotinib | 0.5747 |
| MCF7 | Momelotinib | 0.3468 |
| MCF7 | Dasatinib | 0.9735 |
| MCF7 | Dovitinib | 0.3654 |
| MCF7 | Enzastaurin | 0.0415 |